Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or OpenAthens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

European Thyroid Journal

Official Journal of the European Thyroid Association

Guidelines for Authors
www.karger.com/etj_guidelines

Aims and Scope
Submission
Conditions
Sections
Ethics
Conflict of Interest
Plagiarism Policy
Arrangement
Color Illustrations
References
Digital Object Identifier (DOI)
Supplementary Material
Self-Archiving/Green Open Access, Author's ChoiceTM,
   Funding Organizations (NIH etc.)

Copy Editing
Proofs
E-pub First
Reprints



Aims and Scope

The European Thyroid Journal publishes papers reporting original research in basic, translational and clinical thyroidology. Original contributions cover all aspects of the field from molecular and cellular biology to immunology and biochemistry, physiology to pathology, and paediatric to adult thyroid diseases with a special focus on thyroid cancer. Readers also benefit from reviews by noted experts, which highlight especially active areas of current research. The journal will further publish formal guidelines in the field, produced and endorsed by the European Thyroid Association.




Submission

Manuscripts written in English (the preferred word-processing package is MSWord®) should be submitted online.

Should you have any problems with your submission, please contact the editorial office:

Esther Bettiol
Editorial Office 'European Thyroid Journal'
S. Karger AG
P.O. Box
CH-4009 Basel (Switzerland)
Tel. +41 61 306 1361
Fax. +41 61 306 1434
etj@karger.com


Suggested reviewers: Names, postal and e-mail addresses of four experts in the appropriate area of research should accompany each manuscript.




Conditions

All manuscripts must be accompanied by a covering letter signed by the corresponding author on behalf of all authors verifying that all the authors have made a significant contribution to the findings and methods in the paper. Assurance should be given that the manuscript is original and not under simultaneous consideration for publication in another journal.

Presentation of manuscripts should conform with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (see N Engl J Med 1997;336:309-315).

All manuscripts are subject to editorial review.

Submission of an article for publication implies the transfer of the copyright from the author to the publisher upon acceptance. Accepted papers become the permanent property of 'European Thyroid Journal' and may not be reproduced by any means, in whole or in part, without the written consent of the publisher.

For legal reasons, we must receive your 'Submission Statement' with your original (hand-written) signature. Please download, print, sign and either fax or scan it to make it legally binding.

It is the authors' responsibility to obtain permission to reproduce illustrations, tables, etc. from other publications.




Sections

The journal consists of the following sections. Authors should indicate the section they wish their article to be considered for. For original papers and reviews, please also indicate which category the article falls into: basic thyroidology, translational thyroidology or clinical thyroidology.

Original Papers: Fully documented reports of original research. They must describe full sets of significant, original experiments in basic, translational clinical thyroidology. An Abstract, Introduction, Materials and Methods, Results, and Discussion sections are required. The abstract should be structured and have no more than 250 words. Consideration for publication is based on originality, novelty, scientific soundness, and appropriate analysis. (Maximum 2,500 words, 40 references, plus tables/figures.)

Reviews: Comprehensive, state-of-the-art papers covering a timely topic by experts in the field. Reviews are usually invited by the Editor but may be unsolicited. Potential authors are asked to contact the Editor-in-Chief before submission in order to avoid clashes with other pending reviews. All review papers are subject to peer-review. An abstract (not structured) of no more than 250 words is required. (Maximum 3,500 words, 75 references, plus tables/figures.)

Letters to the Editor: Encouraged if they directly concern articles recently published in this journal. If accepted, the Editor reserves the right to submit such letters to the authors of the articles concerned prior to publication in order to permit them to respond in the same issue of the journal. In exceptional cases, Letters to the Editor may also address data published in another journal or that concern general subjects related to matters discussed in the journal. No abstract is required. (Maximum 1,200 words, 10 references.)

Case Reports: European Thyroid Journal accepts a limited number of case reports. The most important clinical details should be included. The journal gives preference to case reports with significant new insights, specific diagnostic methodology or with an extremely unusual and memorable course. Submissions can be based around a case or a number of similar cases. The most important aspect of the presentation is that it should provide a new perspective on a recognized clinical scenario or may represent an entirely new clinical condition. The novel aspects of the case(s) may be in the phenotype, the presentation, the investigation and/or the management.
Submissions of case reports should include a box containing two questions with their short answers: What is known about this topic? What does this case report add?

Editorials are usually invited by the Editor and provide comments on specifically selected articles published in the 'European Thyroid Journal'. Please send suggestions to the Editor.

Authors should indicate the section and category they wish their article to be considered for.




Ethics

Published research must comply with the guidelines for human studies and animal welfare regulations. Authors should state in the 'Material and Methods' section that subjects have given their informed consent and that the study protocol has been approved by the institute's committee on human research. Further, they should also state that animal experiments conform to institutional standards.




Conflict of Interest

Authors are required to disclose any sponsorship or funding arrangements relating to their research and all authors should disclose any possible conflicts of interest. Conflict of interest statements should be placed on the title page, but will be published at the end of the article.




Plagiarism Policy

Whether intentional or not, plagiarism is a serious violation. We define plagiarism as a case in which a paper reproduces another work with at least 25% similarity and without citation.
If evidence of plagiarism is found before/after acceptance or after publication of the paper, the author will be offered a chance for rebuttal. If the arguments are not found to be satisfactory, the manuscript will be retracted and the author sanctioned from publishing papers for a period to be determined by the responsible Editor(s).




Arrangement

Pages should be numbered throughout the manuscript text.
Title page: The first page of each paper should indicate the title, the authors' names, the institute where the work was conducted, a short title for use as running head, conflict of interest statement, and word count. Manuscripts are to be double-spaced and formatted using the same font, size 12 throughout text and references.

Full address: The exact postal address of the corresponding author complete with postal code must be given at the bottom of the title page. Please also supply phone and fax numbers, as well as e-mail address.

Key words: Please supply 3–10 key words in English that reflect the content of the paper.

Abstract: Each paper needs an abstract of up to 250 words and should be structured as follows:
Background: What is the major motive that prompted the study?
Objectives: What is the purpose of the study?
Methods: How was the study done?
Results: Most important findings.
Conclusions: Most important conclusions.
Structured abstracts are not needed for reviews.

Footnotes: Footnotes should be avoided. When essential, they are numbered consecutively and typed at the foot of the appropriate page.

Units: All articles must be submitted with measurements expressed in SI units.

Tables and illustrations: Tables and illustrations (both numbered in Arabic numerals) should be prepared on separate pages. Tables require a heading and figures a legend. Due to technical reasons, figures with a screen background should not be submitted. When possible, group several illustrations in one block for reproduction (max. size 180x223 mm) or provide crop marks. Electronically submitted b/w half-tone and color illustrations must have a final resolution of 300 dpi after scaling (final size), line art drawings one of 800–1,200 dpi. Figure files should not be embedded in a document file but submitted separately.




Color Illustrations

Online edition: Color illustrations are reproduced free of charge. In the print version, the illustrations are reproduced in black and white. Please avoid referring to the colors in the text and figure legends.

Print edition: Up to 6 color illustrations per page can be integrated within the text at CHF 960.– per page.The inability to pay the color charges will not necessarily prejudice reproduction of the figures in color; this will be decided on by the Editor.




References

In the text identify references by Arabic numerals [in square brackets]. Material submitted for publication but not yet accepted should be noted as 'unpublished data' and not be included in the reference list. The list of references should include only those publications which are cited in the text. Do not alphabetize; number references in the order in which they are first mentioned in the text. The surnames of the authors followed by initials should be given. There should be no punctuation other than a comma to separate the authors. Preferably, please cite all authors. Abbreviate journal names according to the Index Medicus system. Also see International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals (www.icmje.org).

Authors using EndNote® may choose the format setting for 'Intervirology' for the correct format of References.

Examples

(a) Papers published in periodicals: Vilhelmsson M, Johansson C, Jacobsson-Ekman G, Crameri R, Zargari A, Scheynius A: The Malassezia sympodialis allergen Mala s 11 induces human dendritic cell maturation, in contrast to its human homologue manganese superoxide dismutase. Int Arch Allergy Immunol 2007;143:155–162.

(b) Papers published only with DOI numbers: Theoharides TC, Boucher W, Spear K: Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol DOI: 10.1159/000063858.

(c) Monographs: Matthews DE, Farewell VT: Using and Understanding Medical Statistics, ed 4, revised. Basel, Karger, 2007.

(d) Edited books: Bartalena L: Prevention; in Wiersinga WM, Kahaly GJ (eds): Graves' Orbitopathy: A Multidisciplinary Approach – Questions and Answers, ed 2, revised. Basel, Karger, 2010, pp 248 –254.




Digital Object Identifier (DOI)

S. Karger Publishers supports DOIs as unique identifiers for articles. A DOI number will be printed on the title page of each article. DOIs can be useful in the future for identifying and citing articles published online without volume or issue information. More information can be found at www.doi.org




Supplementary Material

Multimedia files and other supplementary files, directly relevant but not essential to the conclusions of a paper, enhance the online version of a publication and increase its visibility on the web. These files will undergo editorial review. The Editors reserve the right to limit the scope and length of the supplementary material. Multimedia and supplementary material should meet production quality standards for publication without the need for any modification or editing. Files should not exceed 10 MB in size. Figures and tables need to have titles and legends, and all files should be supplied separately and labeled clearly. All supplementary material should be referred to in the main text. A DOI number will be assigned to supplementary material and it will be hosted online at https://karger.figshare.com under a CC BY license.




Self-Archiving/Green Open Access

Karger permits authors to archive their pre-prints (i.e. pre-peer review) or post-prints (i.e. accepted manuscript after peer review but before production) on their personal or their institution’s internal website. In addition, authors may post their accepted manuscripts in public Open Access repositories and scientific networks (e.g. ResearchGate or Mendeley) no earlier than 12 months following publication of the final version of their article. For all self-archiving, the posted manuscripts must:

  • Be used for noncommercial purposes only
  • Be linked to the final version on www.karger.com
  • Include the following statement:

‘This is the peer-reviewed but unedited manuscript version of the following article: [insert full citation, e.g. Cytogenet Genome Res 2014;142:227–238 (DOI: 10.1159/000361001)]. The final, published version is available at http://www.karger.com/?doi=[insert DOI number].’

It is the author’s responsibility to fulfill these requirements.

For papers published online first with a DOI number only, full citation details must be added as soon as the paper is published in its final version. This is important to ensure that citations can be credited to the article.

Manuscripts to be archived in PubMed Central due to funding requirements will be submitted by Karger on the author’s behalf [see Funding Organizations (NIH etc.)].

For self-archiving Author's ChoiceTM (Gold Open Access) articles, see Author's ChoiceTM.


Author's ChoiceTM

Karger’s Author's ChoiceTM service broadens the reach of your article and gives all users worldwide free and full access for reading, downloading and printing at www.karger.com. The option is available for a one-time fee of CHF 3,000.00, which is a permissible cost in grant allocation. More information can be found at www.karger.com/authors_choice.
The final, published version of the article may be posted at any time and in any repository or on other websites, in accordance with the relevant Creative Commons license. Reposted Open Access articles must:

  • Follow the terms of the relevant Creative Commons license
  • Be linked to the final version on www.karger.com
  • Include the following statement:

‘The final, published version of this article is available at http://www.karger.com/?doi=[insert DOI number].’

It is the author’s responsibility to fulfill these requirements.

For papers published online first with a DOI number only, full citation details must be added as soon as the paper is published in its final version. This is important to ensure that citations can be credited to the article.


Funding Organizations (NIH etc.)

The U.S. National Institutes of Health (NIH) Public Access Policy mandates that accepted, peer-reviewed manuscripts are archived in its digital database, PubMed Central (PMC), within 12 months of the official publication date. As a service to authors, Karger submits NIH-funded articles to PMC on behalf of the authors immediately upon publication. The NIH assigns a PMCID within approximately 1 month and the manuscript will appear in PMC after a 12-month embargo. For authors making their paper Open Access through Author's ChoiceTM, the embargo will be overridden, thereby accelerating the accessibility of the article. Karger also complies with other funders’ requirements (including Wellcome Trust and RCUK) for submission to PMC.
Authors should include information on their grant in the Acknowledgements section of their papers.




Copy Editing

All manuscripts accepted for publication by Karger are subject to copy editing. Changes introduced by the copy editor and/or questions will be marked in the manuscript so please be sure to check the proofs against the manuscript. The copy edited manuscript will be returned along with the proofs.




Proofs

Unless indicated otherwise, proofs are sent to the corresponding author and should be returned with the least possible delay. Alterations made in proofs, other than the correction of printer's errors, are charged to the author. No page proofs are supplied.




E-pub First

All articles are published electronically ahead of print with a DOI number and are supplemented later with the definite reference of the printed version. The articles become available immediately after the authors' approval to publication, with the added advantage of being citable much earlier than in print. Authors can influence the time of appearance by promptly returning the proofs.




Reprints

Order forms and a price list are sent with the proofs. Orders submitted after the issue is printed are subject to considerably higher prices.